Ein Blog der ZHAW Zürcher Hochschule für Angewandte Wissenschaften
This online information event, taking place on 07 October 2021, will focus on IMI’s impact on patient involvement. It will explore key challenges of these projects and demonstrate how IMI contributed. IMI projects are developing resources and showcasing best practices when it comes to the question of how and when best involve patients in research. […]
The Innovative Medicines Initiative (IMI) is launching the last Calls for proposals under the IMI2 programme, with topics on tackling cancer through artificial intelligence, antimicrobial resistance, neurodegenerative diseases, rare disease diagnosis, and more. Deadline for submission is 29 Sep 2020. Further Information Schlagwörter: IMI, IMI2 programme, innovative Medicines initiative
The Innovative Medicines Initiative has now launched IMI2 – Call 21 on the development of therapeutics and diagnostics combatting coronavirus infections. Schlagwörter: coronavirus infections, IMI
The Innovative Medicines Initiative (IMI) has launched its 20th Call for proposals on 21 January 2020. It is a standard, two-stage call for proposals. Deadline for stage one is 21 April 2020. The new call includes the following topics: Schlagwörter: IMI, innovative Medicines initiative
The Innovative Medicines Initiative (IMI) has published draft topic texts for the next call for proposals, planned for 21 January 2020. IMI2 – Call 20 Schlagwörter: IMI, innovative Medicines initiative
IMI2 has just published the indicative topics and draft topic texts for the next calls. The following topics are currently under consideration for inclusion in future IMI calls for proposals: Schlagwörter: IMI, innovative Medicines initiative
IMI’s first scientific symposium will take place on 22 and 23 October 2018 in Brussels. This event will reflect on 10 years of activity, and present results and work carried out by IMI projects. The scientific programme will cover four areas in four half-day sessions: New targets, tools and pathways From concept to trial […]
Innovative Medicines Initiative (IMI) has launched Call 13 for proposals covering diabetes, antimicrobial resistance, neurodegenerative diseases, cancer, and medicines safety during pregnancy and breastfeeding, to name just a few. The total budget of the Call is EUR 223 million, around half of which comes from the EU’s Horizon 2020 programme, and half of which comes […]
The IMI2 Partnering Platform has now been updated with the future topics foreseen for the 13th IMI2 call. Schlagwörter: Cooperation, IMI, Networking, Platform, SME
Every year, the IMI Stakeholder Forum gathers Innovative Medicines Initiative (IMI) stakeholders in health and medicines R&D and provides them with an opportunity to learn about and discuss IMI’s latest activities and plans. More information on the event will be published shortly. IMI’s Stakeholder Forum is an excellent opportunity for all who are interested in […]